This company listing is no longer active
ResApp Health Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 0/6
Wichtige Informationen
-0.5%
Wachstumsrate der Gewinne
4.9%
EPS-Wachstumsrate
Healthcare Services Wachstum der Industrie | 42.6% |
Wachstumsrate der Einnahmen | 93.9% |
Eigenkapitalrendite | -1,029.0% |
Netto-Marge | -186.2% |
Letzte Ertragsaktualisierung | 30 Jun 2022 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?
Dec 31Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?
Aug 26Here's Why We're Watching ResApp Health's (ASX:RAP) Cash Burn Situation
May 08Analysts Are Optimistic We'll See A Profit From ResApp Health Limited (ASX:RAP)
Feb 25Companies Like ResApp Health (ASX:RAP) Are In A Position To Invest In Growth
Dec 23Aufschlüsselung der Einnahmen und Ausgaben
Wie ResApp Health Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
---|---|---|---|---|
30 Jun 22 | 4 | -7 | 5 | 6 |
31 Mar 22 | 3 | -7 | 4 | 5 |
31 Dec 21 | 0 | -7 | 4 | 5 |
30 Sep 21 | 0 | -7 | 4 | 5 |
30 Jun 21 | 1 | -7 | 4 | 4 |
31 Mar 21 | 1 | -7 | 4 | 5 |
31 Dec 20 | 0 | -8 | 4 | 5 |
30 Sep 20 | 0 | -8 | 3 | 6 |
30 Jun 20 | 0 | -8 | 3 | 7 |
31 Mar 20 | 0 | -7 | 3 | 6 |
31 Dec 19 | 0 | -6 | 2 | 6 |
30 Sep 19 | 0 | -6 | 2 | 6 |
30 Jun 19 | 0 | -5 | 2 | 6 |
31 Mar 19 | 0 | -6 | 1 | 7 |
31 Dec 18 | 0 | -7 | 1 | 7 |
30 Sep 18 | 0 | -7 | 1 | 6 |
30 Jun 18 | 0 | -7 | 2 | 6 |
31 Mar 18 | 0 | -6 | 3 | 5 |
31 Dec 17 | 0 | -6 | 3 | 4 |
30 Sep 17 | 0 | -8 | 6 | 4 |
30 Jun 17 | 0 | -10 | 8 | 3 |
31 Mar 17 | 0 | -10 | 7 | 3 |
31 Dec 16 | 0 | -9 | 7 | 2 |
30 Sep 16 | 0 | -6 | 5 | 1 |
30 Jun 16 | 0 | -3 | 2 | 1 |
31 Mar 16 | 0 | -3 | 2 | 1 |
31 Dec 15 | 0 | -2 | 2 | 1 |
30 Sep 15 | 0 | -1 | 1 | 0 |
Qualität der Erträge: RAP is currently unprofitable.
Wachsende Gewinnspanne: RAP is currently unprofitable.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: RAP is unprofitable, and losses have increased over the past 5 years at a rate of 0.5% per year.
Beschleunigtes Wachstum: Unable to compare RAP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Erträge im Vergleich zur Industrie: RAP is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (1.4%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: RAP has a negative Return on Equity (-1028.99%), as it is currently unprofitable.